Related Experiment Video
Updated: Aug 20, 2025

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Hypocellular AML versus MDS-diagnostic challenge case report with review of literature
Ravi Jacob1, Himanshu Dhanda1, Sartaj Ali1
1ICMR-National Institute of Pathology, Safdarjung Hospital Campus New Delhi, India.
Abstract:
Hypocellular AML being a rare entity with considerable overlapping features and characteristics with various other entities brings a need to have a better and clear understanding of hypocellular AML to differentiate in the decision-making process for therapeutic patient management. With some degree of dysplasia inherently associated with AML it is challenging to differentiate hypocellular AML from Myelodysplastic syndromes. We present a case report where the diagnostic dilemma in an elderly male patient who presented with fever, pallor, weight loss and fatiguability. On clinical examination, the patient had hepatomegaly. The patient was non-affording and was hence given supportive treatment, and he died soon after. Here the diagnostic dilemma is discussed along with the review of literature on hypocellular AML. A better and clear understanding of hypocellular AML is required to differentiate it from other entities due to the considerable overlap in presentation hence improving the decision-making process for therapeutic patient management. The shortcomings are realised, especially when the bone marrow cellularity is less than 10%. Our case report is written to enrich more understanding of the limited published literature on the subject.
Insights
Hypocellular acute myeloid leukemia (AML) presents diagnostic challenges due to overlapping features with other conditions. Clearer understanding is crucial for accurate patient management and treatment decisions.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Hypocellular acute myeloid leukemia (AML) is a rare subtype with overlapping clinical and pathological features.
- Differentiating hypocellular AML from Myelodysplastic Syndromes (MDS) is challenging due to inherent dysplasia in AML.
Observation:
- A case report details an elderly male patient presenting with fever, pallor, weight loss, fatigue, and hepatomegaly.
- The patient, unable to afford advanced treatment, received only supportive care and succumbed shortly thereafter.
Findings:
- Diagnostic dilemmas in hypocellular AML are highlighted, particularly when bone marrow cellularity is below 10%.
- The case underscores the need for improved understanding to distinguish hypocellular AML from other hematological disorders.
Implications:
- Enhanced diagnostic clarity for hypocellular AML is essential for effective therapeutic patient management.
- Further research and literature enrichment are needed to address the limited published data on this rare AML subtype.

